Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Recombinant Peptides market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Peptidesmarket, defines the market attractiveness level of Recombinant Peptides market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Recombinant Peptides industry, describes the types of Recombinant Peptides market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Peptides market and the development prospects and opportunities of Recombinant Peptides industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Peptides market in Chapter 13.
By Player:
Cipla Ltd
Hospira
Actavis
Amgen
Wockhardt Ltd
Sandoz Pharma
Stada Arzneimittel
Biocon Ltd
By Type:
Glucagon
Calcitonin
Other
By End-User:
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Recombinant Peptides Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Recombinant Peptides Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Recombinant Peptides Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Recombinant Peptides Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Recombinant Peptides Market Analysis and Outlook to 2022
-
7.1 Global Recombinant Peptides Consumption (2017-2022)
-
7.2 United States Recombinant Peptides Consumption (2017-2022)
-
7.3 Europe Recombinant Peptides Consumption (2017-2022)
-
7.4 China Recombinant Peptides Consumption (2017-2022)
-
7.5 Japan Recombinant Peptides Consumption (2017-2022)
-
7.6 India Recombinant Peptides Consumption (2017-2022)
-
7.7 South Korea Recombinant Peptides Consumption (2017-2022)
8 Region and Country-wise Recombinant Peptides Market Analysis and Outlook to 2028
-
8.1 Global Recombinant Peptides Consumption Forecast (2022-2028)
-
8.2 United States Recombinant Peptides Consumption Forecast (2022-2028)
-
8.3 Europe Recombinant Peptides Consumption Forecast (2022-2028)
-
8.4 China Recombinant Peptides Consumption Forecast (2022-2028)
-
8.5 Japan Recombinant Peptides Consumption Forecast (2022-2028)
-
8.6 India Recombinant Peptides Consumption Forecast (2022-2028)
-
8.7 South Korea Recombinant Peptides Consumption Forecast (2022-2028)
9 Global Recombinant Peptides Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Peptides Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Glucagon Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Calcitonin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Peptides Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Blood Disorders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Global Recombinant Peptides Market Outlook by Types and Applications to 2028
-
10.1 Global Recombinant Peptides Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Glucagon Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Calcitonin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Recombinant Peptides Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Recombinant Peptides Import and Export Analysis (Top 5 Countries)
-
11.1 Global Recombinant Peptides Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Recombinant Peptides Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Recombinant Peptides Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Recombinant Peptides Market Competitive Analysis
-
14.1 Cipla Ltd
-
14.1.1 Cipla Ltd Company Details
-
14.1.2 Cipla Ltd Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Cipla Ltd Recombinant Peptides Product and Service
-
14.2 Hospira
-
14.2.1 Hospira Company Details
-
14.2.2 Hospira Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Hospira Recombinant Peptides Product and Service
-
14.3 Actavis
-
14.3.1 Actavis Company Details
-
14.3.2 Actavis Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Actavis Recombinant Peptides Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Recombinant Peptides Product and Service
-
14.5 Wockhardt Ltd
-
14.5.1 Wockhardt Ltd Company Details
-
14.5.2 Wockhardt Ltd Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Wockhardt Ltd Recombinant Peptides Product and Service
-
14.6 Sandoz Pharma
-
14.6.1 Sandoz Pharma Company Details
-
14.6.2 Sandoz Pharma Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sandoz Pharma Recombinant Peptides Product and Service
-
14.7 Stada Arzneimittel
-
14.7.1 Stada Arzneimittel Company Details
-
14.7.2 Stada Arzneimittel Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Stada Arzneimittel Recombinant Peptides Product and Service
-
14.8 Biocon Ltd
-
14.8.1 Biocon Ltd Company Details
-
14.8.2 Biocon Ltd Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Biocon Ltd Recombinant Peptides Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Recombinant Peptides
-
Figure Recombinant Peptides Picture
-
Table Global Recombinant Peptides Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Peptides Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Peptides Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Recombinant Peptides Consumption by Country (2017-2022)
-
Figure United States Recombinant Peptides Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Peptides Consumption and Growth Rate (2017-2022)
-
Figure China Recombinant Peptides Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Peptides Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Peptides Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Peptides Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Peptides Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Recombinant Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glucagon Consumption and Growth Rate (2017-2022)
-
Figure Global Calcitonin Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Glucagon Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Calcitonin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Recombinant Peptides Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Recombinant Peptides Export by Region (Top 5 Countries) (2017-2028)
-
Table Cipla Ltd (Foundation Year, Company Profile and etc.)
-
Table Cipla Ltd Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Ltd Recombinant Peptides Product and Service
-
Table Hospira (Foundation Year, Company Profile and etc.)
-
Table Hospira Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hospira Recombinant Peptides Product and Service
-
Table Actavis (Foundation Year, Company Profile and etc.)
-
Table Actavis Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Recombinant Peptides Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Recombinant Peptides Product and Service
-
Table Wockhardt Ltd (Foundation Year, Company Profile and etc.)
-
Table Wockhardt Ltd Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wockhardt Ltd Recombinant Peptides Product and Service
-
Table Sandoz Pharma (Foundation Year, Company Profile and etc.)
-
Table Sandoz Pharma Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz Pharma Recombinant Peptides Product and Service
-
Table Stada Arzneimittel (Foundation Year, Company Profile and etc.)
-
Table Stada Arzneimittel Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stada Arzneimittel Recombinant Peptides Product and Service
-
Table Biocon Ltd (Foundation Year, Company Profile and etc.)
-
Table Biocon Ltd Recombinant Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Ltd Recombinant Peptides Product and Service
-
